The DOI matches its Crossref record; 117 of the 118 references it cites were found in a registry or an index.
A brief review on solid lipid nanoparticles: part and parcel of contemporary drug delivery systems
Open accessAbstract
Drug delivery technology has a wide spectrum, which is continuously being upgraded at a stupendous speed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SLNs, characterized by a solid lipid core stabilized with surfactants, provide high stability, reproducibility, and scalability, whereas NLCs, incorporating both solid and liquid lipids, improve drug loading, stability, and release control [29].”
From Statins as Antifungal Agents: A Review on Drug Repurposing and Nanotechnology-Driven Delivery Strategies (2025) · cites this paper as [29]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“SLNs, characterized by a solid lipid core stabilized with surfactants, provide high stability, reproducibility, and scalability, whereas NLCs, incorporating both solid and liquid lipids, improve drug loading, stability, and release control [29].”
From Statins as Antifungal Agents: A Review on Drug Repurposing and Nanotechnology-Driven Delivery Strategies (2025) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,836
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,158
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00118-7 · Cited by 2,116
Nanoparticle uptake: The phagocyte problem
Gustafson, H. H., Holt‐Casper, D., Grainger, D. W., & Ghandehari, H. (2015) · Nano Today · doi:10.1016/j.nantod.2015.06.006 · Cited by 1,458
Nanotech approaches to drug delivery and imaging
Sahoo, S. K., & Labhasetwar, V. D. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02903-9 · Cited by 1,224
Solid lipid nanoparticles: A modern formulation approach in drug delivery system
Mukherjee, S., Ray, S., & Thakur, R. S. (2009) · Indian Journal of Pharmaceutical Sciences · doi:10.4103/0250-474x.57282 · Cited by 1,001
Solid lipid nanoparticles (SLN) for controlled drug delivery – Drug release and release mechanism
Mühlen, A. Z., Schwarz, C., & Mehnert, W. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00150-1 · Cited by 945
Lammers, T., Aime, S., Hennink, W. E., Storm, G., & Kiessling, F. M. (2011) · Accounts of Chemical Research · doi:10.1021/ar200019c · Cited by 906
Freitas, C., & Müller, R. H. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00092-1 · Cited by 690
Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles
Li, H., Zhao, X. B., Ma, Y., Zhai, G., Li, L., & Lou, H. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.10.002 · Cited by 666
Lipid nanoparticles for improved topical application of drugs for skin diseases☆
SCHAFERKORTING, M., MEHNERT, W., & KORTING, H. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.006 · Cited by 614
An emerging focus on lipids in extracellular vesicles
Skotland, T., Sagini, K., Sandvig, K., & Llorente, A. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.03.002 · Cited by 585
Schwarz, C., Mehnert, W., Lucks, J. S., & Müller, R. H. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)90047-7 · Cited by 574
Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties
Jenning, V., Schäfer‐Korting, M., & Gohla, S. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00223-0 · Cited by 548
Jenning, V., Gysler, A., Schäfer‐Korting, M., & Gohla, S. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(99)00075-2 · Cited by 529
Freitas, C., & Müller, R. H. (1999) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(98)00074-5 · Cited by 484
Yang, S. C., Lu, L. F., Cai, Y., Zhu, J. B., Liang, B. W., & Yang, C. Z. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00007-3 · Cited by 475
Schubert, M. (2003) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00130-3 · Cited by 455
Preparation of solid lipid nanoparticles by a solvent emulsification–diffusion technique
Trotta, M., Debernardi, F., & Caputo, O. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00135-2 · Cited by 439
Lipid nanoparticles for parenteral delivery of actives
Joshi, M. D., & Müller, R. H. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.003 · Cited by 435
Crystallization tendency and polymorphic transitions in triglyceride nanoparticles
Bunjes, H., Westesen, K., & Koch, M. H. J. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)04286-5 · Cited by 426
Müller-Goymann, C. C. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.03.028 · Cited by 404
Nanotheranostics and image-guided drug delivery: current concepts and future directions
Lammers, T., Kiessling, F., Hennink, W. E., & Storm, G. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100228v · Cited by 397
Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability
Luo, Y., Chen, D., Ren, L., Zhao, X., & Qin, J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.05.010 · Cited by 395
Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin
Cavalli, R., Gasco, M. R., Chetoni, P., Burgalassi, S., & Saettone, M. F. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00080-7 · Cited by 389
Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery
Liu, J., Hu, W. S., Chen, H., Ni, Q., Xu, H., & Yang, X. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.08.007 · Cited by 384
Manjunath, K., & Venkateswarlu, V. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.06.006 · Cited by 381
Cosmetic applications for solid lipid nanoparticles (SLN)
Wissing, S. A. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00684-1 · Cited by 366
Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin
Kakkar, V., Singh, S., Singla, D., & Kaur, I. P. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201000310 · Cited by 352
Kovačević, A. B., Savic, S. D., Vuleta, G. M., Müller, R. H., & Keck, C. M. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.12.036 · Cited by 342
Improvement of drug safety by the use of lipid-based nanocarriers
Lim, S. B., Banerjee, A., & Önyüksel, H. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.06.002 · Cited by 325
Body Distribution of Camptothecin Solid Lipid Nanoparticles After Oral Administration
Yang, S., Zhu, J., Yu, L., Liang, B., & Yang, C. (1999) · Pharmaceutical Research · doi:10.1023/a:1018888927852 · Cited by 324
Fundaro', A., Cavalli, R., Bargoni, A., Vighetto, D., Zara, G. P., & Gasco, M. R. (2000) · Pharmacological Research · doi:10.1006/phrs.2000.0695 · Cited by 317
Oral bioavailability of cyclosporine: Solid lipid nanoparticles (SLN®) versus drug nanocrystals
Müller, R. H., Runge, S., Ravelli, V., Mehnert, W., Thünemann, A. F., & Souto, E. B. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.02.045 · Cited by 304
Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin
Subedi, R. K., Kang, K. W., & Choi, H. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.04.008 · Cited by 302
Paliwal, R., Paliwal, S. R., Vaidya, B., Khatri, K., Goyal, A. K., Mishra, N., Mehta, A., & Vyas, S. P. (2008) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2008.08.003 · Cited by 288
Kheradmandnia, S., Vasheghani‐Farahani, E., Nosrati, M., & Atyabi, F. (2010) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2010.06.003 · Cited by 278
Oral solid lipid nanoparticle-based antitubercular chemotherapy
Pandey, R., Sharma, S., & Khuller, G. K. (2005) · Tuberculosis · doi:10.1016/j.tube.2005.08.009 · Cited by 271
Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting
Alex, M. R. A., Chacko, A. J., Jose, S., & Souto, E. B. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.10.002 · Cited by 267
Brain uptake of thiamine-coated nanoparticles
Lockman, P. R., Oyewumi, M. O., Koziara, J. M., Roder, K. E., Mumper, R. J., & Allen, D. D. (2003) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.08.006 · Cited by 260
Quantum dot-based theranostics
Ho, Y., & Leong, K. W. (2009) · Nanoscale · doi:10.1039/b9nr00178f · Cited by 258
Solid Lipid Nanoparticles: A Review
., S. C. V., Viral, S., & Umesh, U. (2011) · Journal of Current Pharma Research · doi:10.33786/jcpr.2011.v01i04.009 · Cited by 250
Diazepam-Loaded Solid Lipid Nanoparticles: Design and Characterization
Abdelbary, G. A., & Fahmy, R. H. (2009) · AAPS PharmSciTech · doi:10.1208/s12249-009-9197-2 · Cited by 249
Preparation of solid lipid nanoparticles using a membrane contactor
Charcosset, C., El-Harati, A. A., & Fessi, H. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.07.023 · Cited by 249
The influence of solid lipid nanoparticles on skin hydration and viscoelasticity – in vivo study
Wissing, S. A., & Müller, R. H. (2003) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(03)00040-7 · Cited by 245
Schwarz, C. (1999) · Journal of Microencapsulation · doi:10.1080/026520499289185 · Cited by 235
Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN)
Schwarz, C., & Mehnert, W. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00222-6 · Cited by 234
Pulmonary toxicity of carbon nanotubes: a systematic report
Kayat, J., Gajbhiye, V., Tekade, R. K., & Jain, N. K. (2010) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2010.06.008 · Cited by 225
Luzzati, V., Tardieu, A., & Gulik‐Krzywicki, T. (1968) · Nature · doi:10.1038/2171028a0 · Cited by 215
Albumin microspheres for study of the reticuloendothelial system.
Scheffel, U., Rhodes, B. A., Natarajan, T. K., & Wagner, H. N. (1972) · PubMed · Cited by 207
Stability of lipid excipients in solid lipid nanoparticles☆
Radomska-Soukharev, A. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.004 · Cited by 206
Hanafy, A., Spahn-Langguth, H., Vergnault, G., Grenier, P., Tubić-Grozdanis, M., Lenhardt, T., & Langguth, P. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.005 · Cited by 203
Alzheimer's disease drug development and the problem of the blood‐brain barrier
Pardridge, W. M. (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.06.003 · Cited by 203
Investigations on the occlusive properties of solid lipid nanoparticles (SLN).
Wissing, S. A., Lippacher, A., & Müller, R. (2001) · PubMed · Cited by 199
Müller, R. H. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.07.006 · Cited by 199
Saupe, A., Gordon, K. C., & Rades, T. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.01.022 · Cited by 198
Drug Delivery Nanoparticles in Skin Cancers
Dianzani, C., Zara, G. P., Maina, G., Pettazzoni, P., Pizzimenti, S., Rossi, F., Gigliotti, C. L., Ciamporcero, E. S., Daga, M., & Barrera, G. (2014) · BioMed Research International · doi:10.1155/2014/895986 · Cited by 187
Exploring dendrimer towards dual drug delivery: pH responsive simultaneous drug-release kinetics
Tekade, R. K., Dutta, T., Gajbhiye, V., & Jain, N. K. (2008) · Journal of Microencapsulation · doi:10.1080/02652040802312572 · Cited by 182
Cationic solid-lipid nanoparticles can efficiently bind and transfect plasmid DNA
Olbrich, C., Bakowsky, U., Lehr, C., Müller, R. H., & Kneuer, C. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00506-5 · Cited by 181
Miglietta, A., Cavalli, R., Bocca, C., Gabriel, L., & Gasco, M. R. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00562-7 · Cited by 180
Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry
Castelli, F., Puglia, C., Sarpietro, M. G., Rizza, L., & Bonina, F. P. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.08.011 · Cited by 178
Studies on oral absorption of stearic acid SLN by a novel fluorometric method
Yuan, H., Chen, J., Du, Y., Hu, F., Zeng, S., & Zhao, H.-L. (2007) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2007.03.002 · Cited by 176
Ma, P., Dong, X., Swadley, C. L., Gupte, A., Leggas, M. L., Ledebur, H. C., & Mumper, R. J. (2009) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2009.1021 · Cited by 174
Li, S., Goins, B., Zhang, L., & Bao, A. (2012) · Bioconjugate Chemistry · doi:10.1021/bc300175d · Cited by 172
Electrosprayed nanoparticles for drug delivery and pharmaceutical applications
Sridhar, R., & Ramakrishna, S. (2013) · Biomatter · doi:10.4161/biom.24281 · Cited by 171
Luo, C.-F., Yuan, M., Chen, M., Liu, S., Liu, Z., Huang, B., Liu, X.-W., & Xiong, W. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.02.064 · Cited by 158
Fangueiro, J. F., Andreani, T., Egea, M. A., García, M. L., Souto, S. B., Silva, A. M., & Souto, E. B. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.11.025 · Cited by 152
Tabatt, K., Sameti, M., Olbrich, C., Müller, R. H., & Lehr, C. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2003.10.015 · Cited by 152
High melting lipid based approach for drug delivery: Solid lipid nanoparticles
Kumar, S., & Randhawa, J. K. (2013) · Materials Science and Engineering C · doi:10.1016/j.msec.2013.01.037 · Cited by 152
Lipid- and Polymer-Based Nanostructures for Cancer Theranostics
Luk, B. T., Fang, R. H., & Zhang, L. (2012) · Theranostics · doi:10.7150/thno.4381 · Cited by 147
Suresh, G., Manjunath, K., Venkateswarlu, V., & Satyanarayana, V. (2007) · AAPS PharmSciTech · doi:10.1208/pt0801024 · Cited by 144
Zara, G. P., Bargoni, A., Cavalli, R., Fundaro', A., Vighetto, D., & Gasco, M. R. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10129 · Cited by 143
Topical Amphotericin B solid lipid nanoparticles: Design and development
Butani, D., Yewale, C. R., & Misra, A. R. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.07.032 · Cited by 143
Gaspar, D. P., Faria, V., Gonçalves, L., Taboada, P., Remuñán‐López, C., & Almeida, A. J. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.11.050 · Cited by 136
Polymeric theranostics: using polymer-based systems for simultaneous imaging and therapy
Krasia‐Christoforou, T., & Georgiou, T. K. (2013) · Journal of Materials Chemistry B · doi:10.1039/c3tb20191k · Cited by 135
Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin
Cavalli, R., Bargoni, A., Podio, V., Muntoni, E., Zara, G. P., & Gasco, M. R. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10368 · Cited by 133
Baboota, S., Shah, F. M., Javed, A., & Alka, A. (2009) · Journal of drug targeting · doi:10.1080/10611860902718672 · Cited by 128
Dendrimer Nanoscaffolds for Potential Theranostics of Prostate Cancer with a Focus on Radiochemistry
Lo, S., Kumar, A., Hsieh, J., & Sun, X. (2013) · Molecular Pharmaceutics · doi:10.1021/mp3005325 · Cited by 126
Chen, H., Moore, T. L., Qi, B., Colvin, D. C., Jelen, E., Hitchcock, D. A., He, J. P., Mefford, O. T., Gore, J. C., Alexis, F., et al. (2013) · ACS Nano · doi:10.1021/nn304369m · Cited by 126
Cavalli, R. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00066-6 · Cited by 125
PHARMACOKINETICS OF DOXORUBICIN INCORPORATED IN SOLID LIPID NANOSPHERES (SLN)
Zara, G. P., Cavalli, R., Fundaro', A., Bargoni, A., Caputo, O., & Gasco, M. R. (1999) · Pharmacological Research · doi:10.1006/phrs.1999.0509 · Cited by 122
Silva, A., Kolosnjaj‐Tabi, J., Bonneau, S., Marangon, I., Boggetto, N., Aubertin, K., Clémеnt, O., Bureau, M. F., Luciani, N., Gazeau, F., et al. (2013) · ACS Nano · doi:10.1021/nn400269x · Cited by 119
Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases
Gendelman, H. E., Anantharam, V., Bronich, T. K., Ghaisas, S., Jin, H., Kanthasamy, A. G., Liu, X., McMillan, J., Mosley, R. L., Narasimhan, B., et al. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.12.014 · Cited by 118
Martins, S., Tho, I., Reimold, I., Fricker, G., Souto, E. B., Ferreira, D., & Brandl, M. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.09.054 · Cited by 117
Naguib, Y. W., Rodriguez, B. L., Li, X., Hursting, S. D., Williams, R. O., & Cui, Z. (2014) · Molecular Pharmaceutics · doi:10.1021/mp4006968 · Cited by 117
Preparation and Enhanced Oral Bioavailability of Cryptotanshinone-Loaded Solid Lipid Nanoparticles
Hu, L., Xing, Q., Meng, J., & Shang, C. (2010) · AAPS PharmSciTech · doi:10.1208/s12249-010-9410-3 · Cited by 116
Kuo, Y., & Chung, J.-F. (2010) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2010.11.037 · Cited by 116
Dynamic Light Scattering Techniques and Their Applications in Food Science
Alexander, M., & Dalgleish, D. G. (2006) · Food Biophysics · doi:10.1007/s11483-005-9000-1 · Cited by 113
Varshosaz, J., Tabbakhian, M., & Mohammadi, M. Y. (2009) · Journal of Liposome Research · doi:10.3109/08982100903443065 · Cited by 106
Corticosteroid solubility and lipid polarity control release from solid lipid nanoparticles
Jensen, L. B., Magnussson, E., Gunnarsson, L., Vermehren, C., Nielsen, H. M., & Petersson, K. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.10.022 · Cited by 105
Increased brain uptake of docetaxel and ketoconazole loaded folate-grafted solid lipid nanoparticles
Venishetty, V. K., Komuravelli, R., Kuncha, M., Sistla, R., & Diwan, P. V. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.03.003 · Cited by 104
Manjunath, K., & Venkateswarlu, V. (2006) · Journal of drug targeting · doi:10.1080/10611860600888850 · Cited by 103
Phagocytic uptake of fluorescent stealth and non-stealth solid lipid nanoparticles
Bocca, C., Caputo, O., Cavalli, R., Gabriel, L., Miglietta, A., & Gasco, M. R. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00282-8 · Cited by 99
Jumaa, M., & Müller, B. W. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(99)00071-8 · Cited by 96
Solid Lipid Nanoparticles for Image-Guided Therapy of Atherosclerosis
Oumzil, K., Ramin, M. A., Lorenzato, C., Hémadou, A., Laroche‐Traineau, J., Jacobin‐Valat, M., Mornet, S., Roy, C.-E., Kauss, T., Gaudin, K., et al. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00590 · Cited by 92
Theranostic applications of mesoporous silica nanoparticles and their organic/inorganic hybrids
Chen, N., Cheng, S., Souris, J. S., Chen, C.-T., Mou, C., & Lo, L. (2013) · Journal of Materials Chemistry B · doi:10.1039/c3tb20249f · Cited by 86
Enhancement of oral bioavailability of pentoxifylline by solid lipid nanoparticles
Varshosaz, J., Minaiyan, M., & Moazen, E. (2010) · Journal of Liposome Research · doi:10.3109/08982100903161456 · Cited by 81
Scaling up feasibility of the production of solid lipid nanoparticles (SLN).
Gohla, S., & Dingler, A. (2001) · PubMed · Cited by 78
del Pozo‐Rodríguez, A., Delgado, D., Solinís, M. Á., Pedraz, J. L., Echevarrı́a, E., Rodríguez, J. M., & Rodríguez‐Gascón, A. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.10.020 · Cited by 77
Venishetty, V. K., Samala, R., Komuravelli, R., Kuncha, M., Sistla, R., & Diwan, P. V. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.08.004 · Cited by 73
Zhang, C., Gu, C., Fan, P., Liu, W., Wan, J., Xu, H., Lam, C. W. K., & Yang, X. (2013) · Molecules · doi:10.3390/molecules181113340 · Cited by 71
Xie, S., Pan, B., Wang, M., Zhu, L., Wang, F., Dong, Z., Wang, X., & Zhou, W. (2010) · Nanomedicine · doi:10.2217/nnm.10.42 · Cited by 70
Jansook, P., Fülöp, Z., & Ritthidej, G. C. (2019) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2019.1569023 · Cited by 67
Wu, Y., Yu, B., Jackson, A., Zha, W., Lee, L. J., & Wyslouzil, B. E. (2009) · Molecular Pharmaceutics · doi:10.1021/mp9000348 · Cited by 63
Gardouh, A. R. (2013) · Journal of Pharmaceutical Research International · doi:10.9734/bjpr/2013/2770 · Cited by 62
DNA delivery via cationic solid lipid nanoparticles (SLNs)
Carrillo, C., Sánchez-Hernández, N., García‐Montoya, E., Pérez‐Lozano, P., Suñé-Negre, J. M., Grau, J. R. T., Suñé, C., & Carmona, M. M. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.02.011 · Cited by 61
Dhakad, R., Tekade, R. K., & Jain, N. K. (2013) · Current Drug Delivery · doi:10.2174/1567201811310040012 · Cited by 61
Awad, T. S., Helgason, T., Weiß, J., Decker, E. A., & McClements, D. J. (2009) · Crystal Growth & Design · doi:10.1021/cg8011684 · Cited by 56
Preparation and characterization of ibuprofen solid lipid nanoparticles with enhanced solubility
Potta, S. G., Minemi, S., Nukala, R. K., Peinado, C., Lamprou, D. A., Urquhart, A. J., & Douroumis, D. (2010) · Journal of Microencapsulation · doi:10.3109/02652048.2010.529948 · Cited by 52
Heible, C. (2015) · Springer eBooks · doi:10.1007/978-3-658-09766-0_3 · Cited by 43
Cationic lipid nanosystems as carriers for nucleic acids
Cortesi, R., Campioni, M., Ravani, L., Drechsler, M., Pinotti, M., & Esposito, E. (2013) · New Biotechnology · doi:10.1016/j.nbt.2013.10.001 · Cited by 42
Priano, L., Zara, G. P., Assawy, N. E., Cattaldo, S., Muntoni, E., Milano, E., Serpe, L., Musicanti, C., Pérot, C., Gasco, M. R., et al. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.02.009 · Cited by 38
Diflucortolone valerate loaded solid lipid nanoparticles as a semisolid topical delivery system
Abdel-Salam, F. S., Elkheshen, S. A., Mahmoud, A. A. K., & Ammar, H. O. (2015) · Bulletin of Faculty of Pharmacy Cairo University · doi:10.1016/j.bfopcu.2015.11.002 · Cited by 36
Salunkhe, S. S., Bhatia, N., & Bhatia, M. (2016) · Drug Delivery · doi:10.3109/10717544.2014.943337 · Cited by 34
Chen, Y., Jin, R.-X., Zhou, Y., Zeng, J., Zhang, H., & Feng, Q.-R. (2006) · PubMed · Cited by 32
Dale, P. J., Kijlstra, J., & Vincent, B. (2005) · Langmuir · doi:10.1021/la052141q · Cited by 17
Nanotechnology in Drug Delivery
Cho, J. M., Kim, S., & Park, K. (2012) · CRC Press eBooks · doi:10.1201/b12935-28 · Cited by 14
Flagged first, then by citations
1 of the 118 references couldn’t be matched to a known paper.
Research works printed but not linked: 19
- M. J.Mycek , R. A.Harvey and P. C.Champe , Pharmacology , Lippincott Williams & Wilkins , Philadelphia, P.A. , 2000
- Scheffel, 1970, J. Nucl. Med., 13, 498
- Gohla, 2001, Pharmazie, 56, 61
- R.Kammari , N. G.Das and S. K.Das , Emerging Nanotechnologies for Diagnostics , Drug Delivery and Medical Devices Micro and Nano Technologies , 2017 , pp. 105–144
- Mehnert, 2001, Adv. Drug Deliv. Rev., 47, 165, 10.1016/S0169-409X(01)00105-3 · DOI
- Freitas, 1999, Eur. J. Pharm. Biopharm., 47, 125, 10.1016/S0939-6411(98)00074-5 · DOI
- Dianzani, 2014, BioMed Res. Int., 895
- Jenning, 2000, Eur. J. Pharm. Biopharm., 49, 211, 10.1016/S0939-6411(99)00075-2 · DOI
- Wissing, 2001, Adv. Drug Delivery Rev., 23, 233
- Wissing, 2001, J. Cosmet. Sci., 52, 313
- Waghmare, 2012, Int. Res. J. Pharm., 3, 100
- Svilenov, 2014, Nanomedicine, 187
- Chen, 2006, China J. Chin. Mater. Med., 31, 376
- Siekmann, 1992, Pharm. Pharmacol. Lett., 1, 123
- Cavalli, 1998, Pharmazie, 53, 392
- Jain, 2013, Drug Deliv., 373
- Liu, 2007, Int. J. Pharm., 328, 191, 10.1016/j.ijpharm.2006.08.007 · DOI
- Wissing, 2003, Int. J. Pharm., 254, 65, 10.1016/S0378-5173(02)00684-1 · DOI
- Mehnert, 2001, Adv. Drug Deliv. Rev., 47, 165, 10.1016/S0169-409X(01)00105-3 · DOI
Cited by
Sorted by citations
Controlled Drug Delivery Systems: Current Status and Future Directions
Adepu, S., & Ramakrishna, S. (2021) · Molecules · doi:10.3390/molecules26195905 · Cited by 1,691
Mehta, M., Bui, T. A., Yang, X., Aksoy, Y. A., Goldys, E. M., & Deng, W. (2023) · ACS Materials Au · doi:10.1021/acsmaterialsau.3c00032 · Cited by 776
Thi, T. T. H., Suys, E. J. A., Lee, J. S., Nguyen, D. H., Park, K. D., & Truong, N. P. (2021) · Vaccines · doi:10.3390/vaccines9040359 · Cited by 551
Recent Progress in Nanostructured Smart Drug Delivery Systems for Cancer Therapy: A Review
Khan, M. I., Hossain, I., Hossain, M. K., Rubel, M. H. K., Hossain, K. M., Mahfuz, A. M. U. B., & Anik, M. I. (2022) · ACS Applied Bio Materials · doi:10.1021/acsabm.2c00002 · Cited by 388
Advancements in nanoparticle-based treatment approaches for skin cancer therapy
Zeng, L., Gowda, B. H. J., Ahmed, M. G., Abourehab, M. A. S., Chen, Z., Zhang, C., Li, J., & Kesharwani, P. (2023) · Molecular Cancer · doi:10.1186/s12943-022-01708-4 · Cited by 377
Metadata
- Authors
- Duan, Y., Dhar, A., Patel, C., Khimani, M., Neogi, S., Sharma, P., Siva Kumar, N., & Vekariya, R. L.
- Affiliations
- Zhengzhou University (CN)
- Jadavpur University (IN)
- P P Savani University (IN)
- Department of Chemical Engineering
- Ton Duc Thang University (VN)
- Corresponding author
- Vekariya, Rohit L.
- ORCID
- Venue
- RSC Advances
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2020
- Volume
- 10
- Issue
- 45
- Pages
- 26777-26791
- ISSN
- 2046-2069 (ISSN-L)
- PMC
- PMC9055574
- OpenAlex
- W3043255293
- Cited by
- 614
- References
- 118
- Citations by year
- 2026: 68 · 2025: 119 · 2024: 139 · 2023: 126 · 2022: 98 · 2021: 58 · 2020: 6
- FWCI
- 6.23
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- RSC Advances (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81903623)
- China Postdoctoral Science Foundation (2019M652586)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Keywords
- solid lipid nanoparticles, nanostructured lipid carriers, drug delivery systems, poorly water-soluble drugs, pharmacokinetics, liposomes, ethosomes, virosomes, deformable liposomes, surfactants, lipid excipients, nanoparticle stability, storage, theranostics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review